Join the club for FREE to access the whole archive and other member benefits.

MaxCyte

Biotechnology company that develops, manufactures and commercialize the next-generation cell-based medicines

MaxCyte is a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization. Over the past 20 years, we have developed and commercialized our proprietary Flow Electroporation® platform, which facilitates complex engineering of a wide variety of cells. Our ExPERT™ platform, which is based on our Flow Electroporation technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATx™, STx™, GTx™, and VLx™; a portfolio of proprietary related processing assemblies or disposables; and software protocols, all supported by a robust worldwide intellectual property portfolio.

Visit website: https://maxcyte.com/

 maxcyte-inc-

 MaxCyte_info

Details last updated 19-Jun-2022

People at MaxCyte

Tarryn Bourhill

Tarryn Bourhill is a molecular biologist and an aspiring science writer

Andrew Mancini

Field Application Scientist at MaxCyte specializing in Cell and Gene Therapy